Office of the Director; Notice of Charter Renewal, 31508 [2021-12380]
Download as PDF
<![CDATA[
31508
Federal Register / Vol. 86, No. 112 / Monday, June 14, 2021 / Notices
HRSA, an operating division
of HHS, is publishing a list of
individuals who may be named to serve
on the Senior Executive Service
Performance Review Board that oversees
the evaluation of performance
appraisals for Senior Executive Service
members for the Fiscal Years 2021 and
2022.
FOR FURTHER INFORMATION CONTACT:
Georgia Lyons, HRSA Executive
Resources, Office of Human Resources,
5600 Fishers Lane, Rm 12N06C,
Rockville, Maryland 20857, or (301)
443–4618.
SUPPLEMENTARY INFORMATION: Title 5,
U.S.C. Section 4314(c)(4) of the Civil
Service Reform Act of 1978, Public Law
95–454, requires that the appointment
of Performance Review Board Members
be published in the Federal Register.
The following individuals may be
named to serve on the Senior Executive
Service Performance Review Board:
Onyekachukwu Anaedozie
Anthony Archeval
Leslie Atkinson
Cynthia Baugh
Tonya Bowers
Adriane Burton
Tina Cheatham
Laura Cheever
Natasha Coulouris
Cheryl Dammons
Elizabeth DeVoss
Diana Espinosa
Catherine Ganey
Alexandra Garcia
Jordan Grossman
Heather Hauck
Danita Hunter
Laura Kavanagh
Martin Kramer
Torey Mack
James Macrae
Susan Monarez
Thomas Morris
Luis Padilla
Krista Pedley
Wendy Ponton
Ashley Rose
Tracey Trautman
Michael Warren
SUMMARY:
Diana Espinosa,
Acting Administrator.
[FR Doc. 2021–12366 Filed 6–11–21; 8:45 am]
Dated: June 9, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–12413 Filed 6–11–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director; Notice of Charter
Renewal
In accordance with Title 42 of the
U.S. Code of Federal Regulations,
Section 217a, notice is hereby given that
the Charter for the Advisory Committee
to the Director, National Institutes of
Health was renewed for an additional
two-year period on May 31, 2021.
It is determined that the Advisory
Committee to the Director, National
Institutes of Health is in the public
interest in connection with the
performance of duties imposed on the
National Institutes of Health by law, and
that these duties can best be performed
through the advice and counsel of this
group.
Inquiries may be directed to Claire
Harris, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail Stop Code 4875), Telephone (301)
496–2123, or harriscl@mail.nih.gov.
Dated: June 8, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
lotter on DSK11XQN23PROD with NOTICES1
Neuroscience, Vision and Low Vision
Technologies Study Section, June 16,
2021, 8:00 a.m. to June 17, 2021, 07:00
p.m., National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD, 20892 which was
published in the Federal Register on
June 08, 2021, 86 FR 30466.
This notice is being amended to
change the meeting start time from 8:00
a.m. to 10:00 a.m. The meeting is closed
to the public.
[FR Doc. 2021–12380 Filed 6–11–21; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; Career Development
(K), Conference Support (R13), and Research
Education (R25) Review.
Date: July 16, 2021.
Time: 09:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Democracy II, 6707 Democracy Blvd.,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John K. Holden, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Suite 920, Bethesda, MD
20892, (301) 496–8775, john.holden@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health, HHS)
Dated: June 9, 2021.
David W Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–12414 Filed 6–11–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4140–01–P
Center For Scientific Review; Notice of
Closed Meetings
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
Notice is hereby given of a change in
the meeting of the Bioengineering of
VerDate Sep<11>2014
17:26 Jun 11, 2021
Jkt 253001
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
E:\FR\FM\14JNN1.SGM
14JNN1
]]>Agencies
[Federal Register Volume 86, Number 112 (Monday, June 14, 2021)]
[Notices]
[Page 31508]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-12380]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director; Notice of Charter Renewal
In accordance with Title 42 of the U.S. Code of Federal
Regulations, Section 217a, notice is hereby given that the Charter for
the Advisory Committee to the Director, National Institutes of Health
was renewed for an additional two-year period on May 31, 2021.
It is determined that the Advisory Committee to the Director,
National Institutes of Health is in the public interest in connection
with the performance of duties imposed on the National Institutes of
Health by law, and that these duties can best be performed through the
advice and counsel of this group.
Inquiries may be directed to Claire Harris, Director, Office of
Federal Advisory Committee Policy, Office of the Director, National
Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda,
Maryland 20892 (Mail Stop Code 4875), Telephone (301) 496-2123, or
[email protected].
Dated: June 8, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-12380 Filed 6-11-21; 8:45 am]
BILLING CODE 4140-01-P
